EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

“Pericoronary adipose tissue attenuation as a marker of global coronary inflammation rather than lesion-specific risk”

Ernestas Dvinelis, Silvija Sakalauske, Guste Cesnaite, Medeine Kapacinskaite, Radoslavas Stasilo, Greta Vrublevska, Justinas Bacevicius, Algridas Tamosiunas, Sigita Glaveckaite

Frontiers in Cardiovascular Medicine · 19.06.2026 · 13

DOI: 10.3389/fcvm.2026.1863906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 19.06.2026. Verfasst von Ernestas Dvinelis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pericoronary adipose tissue (PCAT) attenuation is a non-invasive imaging marker of coronary vascular inflammation. However, its relationship with clinical outcomes and its relevance at different levels of analysis remain incompletely understood. This study aimed to investigate the association between PCAT attenuation and major adverse cardiovascular events (MACE), with a focus on its role as a marker of coronary inflammatory burden at the lesion and patient levels. Methods and results In this retrospective cohort study, 772 participants were included (56.6% men). Lesions from patients who experienced MACE exhibited higher (less negative) PCAT attenuation compared with those without events. PCAT attenuation was assessed at the patient and lesion levels. Associations with MACE were analyzed using logistic regression and mixed-effects models. ROC analysis evaluated predictive performance. Linear mixed-effects models showed lesion-level mean and maximum PCAT attenuation were higher in patients with MACE (ΔHU = −1.941, 95% CI −3.563 to −0.320; p = 0.019, and ΔHU = −2.899, 95% CI −4.838 to −0.961, p = 0.003, respectively), including after adjustment for cardiovascular risk factors. However, lesion-level PCAT attenuation was not associated with MACE in generalized linear mixed-effects models. At the patient level, higher PCAT attenuation values were consistently associated with increased hazard of MACE during follow-up in both univariable (HR 1.046, 95% CI 1.013–1.081; p = 0.006) and multivariable analyses (HR 1.014, 95% CI 1.004–1.024; p = 0.006). Despite these associations, discriminatory performance of PCAT attenuation was modest (AUC 0.591, 95% CI 0.534–0.644), indicating limited ability to distinguish individuals at risk.

Conclusions

PCAT attenuation is associated with adverse cardiovascular outcomes at the patient level, supporting its role as a marker of global coronary inflammatory burden, with stronger, more consistent associations at the patient level than at the lesion level. While it reflects biologically relevant inflammatory processes, its limited discriminatory performance suggests that PCAT attenuation is best interpreted as a complementary marker within the broader context of clinical and imaging risk assessment.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosiscoronary artery diseasemajor adverse cardiovascular eventspericoronary adipose tissuevascular inflammation

Autor:innen und Institutionen

  • Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Center of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Department of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.

Zitieren

APA

Dvinelis, E., Sakalauske, S., Cesnaite, G., Kapacinskaite, M., Stasilo, R., Vrublevska, G., Bacevicius, J., Tamosiunas, A., & Glaveckaite, S. (2026). “Pericoronary adipose tissue attenuation as a marker of global coronary inflammation rather than lesion-specific risk”. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1863906

Vancouver

Dvinelis E, Sakalauske S, Cesnaite G, Kapacinskaite M, Stasilo R, Vrublevska G, et al. “Pericoronary adipose tissue attenuation as a marker of global coronary inflammation rather than lesion-specific risk”. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1863906

BibTeX
@article{Dvinelis2026,
  author = {Dvinelis, Ernestas and Sakalauske, Silvija and Cesnaite, Guste and Kapacinskaite, Medeine and Stasilo, Radoslavas and Vrublevska, Greta and Bacevicius, Justinas and Tamosiunas, Algridas and Glaveckaite, Sigita},
  title = {“Pericoronary adipose tissue attenuation as a marker of global coronary inflammation rather than lesion-specific risk”},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1863906}
}
Kostenlos starten →